Nevan C. Elam - 28 Dec 2023 Form 4 Insider Report for Savara Inc (SVRA)

Role
Director
Signature
/s/ David Lowrance, as attorney-in-fact for Nevan Elam
Issuer symbol
SVRA
Transactions as of
28 Dec 2023
Net transactions value
-$372,570
Form type
4
Filing time
29 Dec 2023, 16:33:48 UTC
Previous filing
15 Dec 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SVRA Common Stock Options Exercise $1,442 +1,758 +2.8% $0.8200* 64,343 28 Dec 2023 Direct
transaction SVRA Common Stock Options Exercise $19,080 +12,000 +19% $1.59* 76,343 28 Dec 2023 Direct
transaction SVRA Common Stock Options Exercise $49,200 +40,000 +52% $1.23* 116,343 28 Dec 2023 Direct
transaction SVRA Common Stock Sale $442,291 -93,843 -81% $4.71 22,500 28 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SVRA Stock Option (Right to Buy) Options Exercise $0 -1,758 -100% $0.000000* 0 28 Dec 2023 Common Stock 1,758 $0.8200 Direct F2
transaction SVRA Stock Option (Right to Buy) Options Exercise $0 -12,000 -100% $0.000000* 0 28 Dec 2023 Common Stock 12,000 $1.59 Direct F3
transaction SVRA Stock Option (Right to Buy) Options Exercise $0 -40,000 -100% $0.000000* 0 28 Dec 2023 Common Stock 40,000 $1.23 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.
F3 The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019.
F4 The shares subject to the option vested and became exercisable on December 16, 2021.